Illustrasjonsfoto

Illustrasjonsfoto

  • Sist revidert: 24.11.2010

Vil du vite mer?

Dette dokumentet er basert på det profesjonelle dokumentet "Migrene" i Norsk Elektronisk Legehåndbok. Referanselisten for dette dokumentet vises nedenfor.

Referanser

  1. Silberstein SD. Migraine. Lancet 2004; 363: 381-91.
  2. Hagen K, Zwart J-A, Vatten L, Stovner LJ, Bovim G. Prevalence of migraine and non-migrainous headache. Head-HUNT - a large population based study. Cephalalgia 2000; 20:900-6.
  3. Hagen K. Genetiske aspekter ved migrene. Tidsskr Nor Lægeforen 2003; 123: 2727-30.
  4. Alstadhaug KB, Salvesen R. Migrenesmerte - mekanismer og konsekvenser for behandling. Tidsskr Nor Lægeforen 2007; 127: 3064-8.
  5. Salvesen R. Nyere synspunkter på etiologi og patofysiologi ved migrene. Tidsskr Nor Lægeforen 1999; 119: 1437-43
  6. Brandes JL. The influence of estrogen on migraine. JAMA 2006; 295: 1824-30.
  7. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of RCBF in classic migraine. Ann Neurol 1981; 9: 344-52.
  8. Stewart W, Staffa J, Lipton R, Ottmann R. Familial risk of migraine: a population based study. Ann Neurol 1997; 41: 166-72.
  9. Fasmer OB, Oedegaard KJ. Migrene og psykiske lidelser. Tidsskr Nor Lægeforen 2004; 124: 2350-3.
  10. Headache Classification Committee. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia 2004; 24: 28-36.
  11. Silberstein SD, Young WB. Migraine aura and prodrome. Semin Neurol 1995; 45: 175-82.
  12. Giffin NJ, Ruggiero L, Lipton RB, et al. A novel approach to the study of premonitory symptoms in migraine using an electronic diary. Neurology 2003; 60: 935-40.
  13. Silberstein SD, Lipton RB. Overview of diagnosis and treatment of migraine. Neurology 1994; 44: 6-16..
  14. Thomsen LL, Eriksen MK, Roemer SF, Anderson I, Olesen J, Russell MB. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 2002; 125: 1379-99.
  15. Stewart WF, Schechter A, Lipton RB. Migraine heterogeneity: disability, pain intensity, attack frequency, and duration. Neurology 1994; 44 :(suppl) S24-39.
  16. Silberstein SD. Migraine symptoms: results of a survey of self-reported migraineurs. Headache 1995; 35: 387-96.
  17. Kaniecki RG. Migraine and tension-type headache: an assessment of challenges in diagnosis. Neurology 2002; 58(suppl 6): S15-20.
  18. Gilmore B, Michael M. Treatment of acute migraine headache. Am Fam Physician 2011; 83: 271-80.
  19. Matchar DB, Young WB, Rosenberg JA, et al. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. http://www.aan.com, 2000 (accessed April 25, 2000).
  20. Duncan CW, Watson DPB, Stein A, et al. Diagnosis and management of headache in adults; summary of SIGN guideline. BMJ 2008; 337: a2329.
  21. Lipton RB, Stewart WF, Stone AM, Lainez MJA, Sawyer JPC. Stratified care vs step care strategies for migraine. The disability in strategies of care (DISC) study: a randomized trial. JAMA 2000; 284: 2599-605.
  22. Lipton RB, Cady RK, O'Quinn S, Hall CB, Stewart WF. Sumatriptan treats the full spectrum of headache in individuals with disabling IHS migraine. Headache 1999; 40: 783-91.
  23. Colman I, Friedman BW, Brown MD et al. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence . BMJ 2008; 336: 1359-61.
  24. Singh A, Alter HJ, Zaia B. Does the addition of dexamethasone to standard therapy for acute migraine headache decrease the incidence of recurrent headache for patients treated in the emergency department? A meta-analysis and systematic review of the literature. Acad Emerg Med 2008; 15: 1223-33.
  25. Hagen K, Stovner LJ. Migrenebehandling ved graviditet og amming. Tidsskr Nor Lægeforen 2006; 126: 3107-9.
  26. Tfelt-Hansen P, Iversen HK. Triptaner i migrænebehandlingen. Ugeskr Læger 2006; 168: 1850-3.
  27. Lipton RB, Stewart WF, Ryan RE, Saper J, Silberstein S, Sheftell F. Efficacy and safety of the nonprescription combination of acetaminophen, aspirin, and caffeine in alleviating headache pain of an acute migraine attack: three double-blind, randomized, placebo-controlled trials. Arch Neurol 1998; 55: 210-17.
  28. Kirthi V, Derry S, Moore RA, et al. Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database of Systematic reviews 2010; 4: CD008041.
  29. Morillo L. Migraine headache. Clin Evid 2001; 6: 990-1005.
  30. Tfelt-Hansen P, Olesen J. Increasing the effect of triptans in migraine. Lancet 2006; 368: 1313-4.
  31. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine. Drugs 2000; 60: 1259-87.
  32. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001; 358: 1668-75.
  33. Brandes JL, Kudrow D, Stark SR, et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA 2007; 297: 1443-54.
  34. Salvesen R. Valg av triptan ved migrene. Tidsskr Nor Lægeforen 2001; 121: 3410-1.
  35. Winner P, Rothner AD, Wooten JD, Webster C, Ames M. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.. Headache 2006; 46: 212-22.
  36. Gaist D. Use and overuse of sumatriptan. Cephalalgia 1999; 19: 735-61.
  37. Contag SA, Bushnell C. Contemporary management of migrainous disorders in pregnancy. Curr Opin Obstet Gynecol 2010; 22: 437-45.
  38. Cassina M, De Gianantonio E et al. Migraine therapy during pregnancy and lactation. Expert Opin Drug Saf 2010; 9: 937-48.
  39. Evans EW, Lorber KC. Use of 5-HT1 agonists in pregnancy. Ann Pharmacother 2008; 42: 543-9.
  40. Johansen JS, Stenberg-Nilsen H (RELIS). . Behandling av migrene i svangerskapet. Nyhetsbrev publisert 15.11.10.
  41. Källén K, Winbladh B. Läkemedel och fosterskador. Propranolol. http://www.janusinfo.se/gravreg/ (Sist endret: juni 2010).
  42. Lee MJ, Guinn D et al. Headache in pregnancy. UpToDate, last updated Mars 19. 2010.
  43. Linde K, Streng A, Jurgens S, et al. Acupuncture for patients with migraine: a randomized controlled trial. JAMA 2005; 293: 2118-25.
  44. Vickers AJ, Rees RW, Zollman CE, et al. Acupuncture for chronic headache in primary care: large, pragmatic, randomised trial. BMJ 2004; 328: 744.
  45. Agency for Health Care Policy and Research, Duke University, Center for Clinical Health Policy Research. Behavioral and physical treatments for migraine headache, technical review 2.2. Rockville, Md.: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1999.
  46. Andrasik F. What does the evidence show? Efficacy of behavioural treatments for recurrent headaches in adults. Neurol Sci 2007; 28(suppl 2): 70-7.
  47. Blanchard EB, Andrasik F, Ahles TA, Teders SJ, O'Keefe D. Migraine and tension-type headache: a meta- analytic review. Behav Ther 1980; 11: 613-31.
  48. Holroyd KA, Penzien DB. Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trials. Pain 1990; 42: 1-13.
  49. Holroyd KA, Penzien DB, Cordingley GE. Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 1991; 31: 333-40.
  50. Campbell JK, Penzien DB, Wall EM, for the U.S. Headache Consortium. Evidence-based guidelines for migraine headache: behavioral and physical treatments. Accessed May 18, 2007, at: http://www.aan.com/professionals/practice/pdfs/gl0089.pdf
  51. Hermann C, Blanchard EB. Biofeedback in the treatment of headache and other childhood pain. Appl Psychophysiol Biofeedback 2002; 27: 143-62.
  52. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55: 754-62.
  53. Linde K, Allais G, Brinkhaus B, et al. Acupuncture for migraine prophylaxis. Cochrane Database of Systematic Reviews 2009; 1: CD001218.
  54. Silberstein SD, Goadsby PJ. Migraine: preventative treatment. Cephalalgia 2002; 22: 491-512.
  55. Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 2003; 289: 65-9.
  56. Modi S, Lowder DM. Medications for migraine prophylaxis. Am Fam Physician 2006; 73: 72-8.
  57. Schrader H, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with angiotensin-converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ 2001; 322: 19-22.
  58. Chronicle E, Mulleners W. Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev 2004; (3): CD003226.
  59. Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004; 291: 965-73.
  60. Rothrock JF. Clinical studies of valproate for migraine prophylaxis. Cephalalgia 1997; 17:81-3
  61. Ramadan NM, Schultz LL, Gikey SJ. Migraine prophylactic drugs: proof of efficacy, utlilization and cost. Cephalalgia 1997; 17:73-80.
  62. Kvan E, Narum S. P-piller med forlenget syklus - et fremskritt?. Tidsskr Nor Lægeforen 2005; 125: 2202-3.
  63. Diener HC, Dodick DW, Aurora SK, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 2010; 30: 804-14.
  64. Etminan M, Takkouche B, Isorna F, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005; 330: 63-5.
  65. Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in women. JAMA 2006; 296: 283-91.
  66. Scher AI, Gudmundsson LS, Sigurdsson S, et al. Migraine headache in middle age and late-life brain infarcts. JAMA 2009; 301: 2563-70.
  67. Kurth T, Kase CS, Schürks M, et al. Migraine and risk of haemorrhagisk stroke in women: prospective cohort study. BMJ 2010; 341: c3659.
  68. Kurth T, Schurks M, Logroscino G et al. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 2008; 337: a636.
  69. Gudmundsson LS, Scher AI, Aspelund T, et al. Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study. BMJ 2010; 341: c3966.
  70. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine: the population-based MRI CAMERA-study. Brain 2005; 128: 2068-77.
  71. Oldman AD, Smitrh LA, McQuay HJ, Moore A. Pharmacological treatments for acute migraine: quantitative systematic review. Pain 2002; 97: 247-57.
  • Adams R D, Victor M, Ropper AH (eds). Principles of Neurology, McGraw-Hill Inc., 1997
  • The International Classification of Headache Disorders. 2nd Edition. Cephalalgiaa 2004; (Suppl 1); 24: 1-160
  • Hunskår S (red). Allmennmedisin, klinisk arbeid. Oslo: ad Notam Gyldendal, 2003
  • Lance JW. Mechanisms and Management of Headache, Oxford: Butterworth-Heineman Ltd, 1993
  • Salvesen R. Medikamentell behandling av migreneanfall. Tidsskr Nor Lægeforen 1996; 116: 2176-9
  • Stovner LJ. Diagnostikk og behandling av hodepine. Tidsskr Nor Lægeforen 1995; 115: 1627-31
Spør legen

Debattregler

Relaterte artikler

Relaterte artikler

Migrene, oversikt

Hva er migrene? Migrene er anfall med ensidig, pulserende hodepine som varer 4-72 timer....

Migrene, behandling

Det finnes flere måter å behandle migrene på. Hva som passer best for deg, avhenger ...

Migrene, årsaker

Det er fortsatt mye som er uklart omkring de kompliserte prosessene som skjer i ...

Norges Migreneforbund

Norges Migreneforbund - Forbundet for alle typer hodepine (NMF) skal ivareta ...

Epilepsi, oversikt

Epilepsi er en samlebetegnelse for ulike typer anfall som skyldes forstyrret ...

NHI.no - Norges største helsenettside. Basert på Nordens mest brukte oppslagsverk for leger og helsepersonell (Norsk Elektronisk Legehåndbok).

©2011 Norsk Helseinformatikk AS. Alle rettigheter er reservert. All informasjon på NHI.no er laget for å gi deg generell kunnskap og er ingen erstatning for innhenting av medisinsk råd eller behandling hos helsepersonell. Dersom du er syk eller trenger medisinsk hjelp av andre grunner, bør du oppsøke lege. NHI er uten ansvar for innholdet på eksterne websteder det er lenket til. Vi tillater ikke reklame for behandlere/ behandlingsmetoder i kommentarfeltene. Alle slike innlegg vil bli slettet.